Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults

INTRODUCTION: Amenamevir is a nonnucleoside antiherpes virus compound available for treating herpes zoster infections. Four studies aimed to determine any potential interactions between amenamevir and ketoconazole, rifampicin, midazolam, or warfarin in healthy male participants. METHODS: Two studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusawake, Tomohiro, den Adel, Martin, Groenendaal-van de Meent, Dorien, Garcia-Hernandez, Alberto, Takada, Akitsugu, Kato, Kota, Ohtsu, Yoshiaki, Katashima, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702381/
https://www.ncbi.nlm.nih.gov/pubmed/29076107
http://dx.doi.org/10.1007/s12325-017-0634-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702381/
https://www.ncbi.nlm.nih.gov/pubmed/29076107
http://dx.doi.org/10.1007/s12325-017-0634-4

Ejemplares similares